*Cleanzine_logo_2a.jpgCleanzine: your weekly cleaning and hygiene industry newsletter 22nd September 2022 Issue no. 1033

Your industry news - first    Number 1 for Recruitment

We strongly recommend viewing Cleanzine full size in your web browser. Click our masthead above to visit our website version.

Search
English French Spanish Italian German Dutch Russian Mandarin


US Environmental Protection Agency approves Actizone F5, Solvay's innovative 24-hour antimicrobial sanitising technology

* Actizone-F5-EPA-registered.jpgSolvay has announced that Actizone F5 has obtained registration by the U. Environmental Protection Agency as a ready-to-use disinfectant for hard surfaces.

Actizone F5 is formulated with a new revolutionary long-lasting technology that reduces bacteria by 99.9% on hard non-porous surfaces for 24 hours, even after multiple touches. It provides initial disinfection after five minutes contact time against a wide range of viruses and bacteria[1] including SARS-CoV-2, the virus that causes Covid-19.

"We are very proud that our technology has achieved this registration," says Oliver Hufer, executive vice president and general manager, Novecare Incubator at Solvay.

"Actizone F5 will soon be available in the United States for the protection of consumers everywhere they go, not just at home but when working, travelling, commuting and simply enjoying day to day life."

Consumers, businesses and institutions continue to search for ways to uphold health standards and feel protected from bacteria and viruses, particularly from SARS-CoV-2 in their daily life settings. By using Actizone F5, hard surfaces are taken out of the transmission mechanism of bacteria as the technology continues sanitising long after surfaces have been cleaned, so consumers can enjoy peace of mind and feel confident knowing they are protected for 24 hours.

"It is a significant achievement," explains Dr Amit Sehgal, technology lead - Actizone - home, health & personal care at Solvay. "From a technical perspective, it transforms the surface from being a vector for the transmission of disease, into an ultrathin transient reservoir of actives that protects people from bacteria until the next application."

Solvay is now working to obtain state registrations for Actizone F5 required to market in specific states. These are expected to be completed during 2022.

Founded in 1863 and now with more than 23,000 employees in 64 countries, Solvay ranks among the world's top three companies for the vast majority of its activities and delivered net sales of $9 billion in 2020.

[1] Staphylococcus aureus [ATCC 6538], Pseudomonas aeruginosa [ATCC 15442], Salmonella enterica [ATCC 10708], Influenza A H1N1 [2009 H1N1; Strain A/Mexico/4108/2009; CDC# 2009712192], Human Rotavirus [Strain WA; ATCC VR-2018], Human Coronavirus [Strain 229E; ATCC VR-740], Human Respiratory syncytial virus [Strain Long; ATCC VR-26], Severe Acute Respiratory Syndrome coronavirus [SARS-CoV-2 strain; USAWA1/2020; BEI Resources # NR52281].

www.solvay.com

2nd December 2021




© The Cleanzine 2022.
Subscribe | Unsubscribe | Hall of Fame | Cookies | Sitemap